Cargando…

Statin Intensity or Achieved LDL? Practice-based Evidence for the Evaluation of New Cholesterol Treatment Guidelines

BACKGROUND: The recently updated American College of Cardiology/American Heart Association cholesterol treatment guidelines outline a paradigm shift in the approach to cardiovascular risk reduction. One major change included a recommendation that practitioners prescribe fixed dose statin regimens ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ross, Elsie Gyang, Shah, Nigam, Leeper, Nicholas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881915/ https://www.ncbi.nlm.nih.gov/pubmed/27227451 http://dx.doi.org/10.1371/journal.pone.0154952

Ejemplares similares

Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?
por: Ibn Elhadj, Zied, et al.
Publicado: (2022)

APLUS: A Python library for usefulness simulations of machine learning models in healthcare
por: Wornow, Michael, et al.
Publicado: (2023)

Intensity of Statin Treatment in Korean Patients with Acute Myocardial Infarction and Very Low LDL Cholesterol
por: Sim, Doo Sun, et al.
Publicado: (2019)

Pre-Treatment with Statins for Coronary Intervention: Pleiotropy of Statins or Effect of LDL-cholesterol Reduction?
por: Habon, Tamas, et al.
Publicado: (2016)

Statin Intensity and Clinical Outcome in Patients with Stable Coronary Artery Disease and Very Low LDL-Cholesterol
por: Lee, Soo Youn, et al.
Publicado: (2016)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Prediction of LDL cholesterol response to statin using transcriptomic and genetic variation
por: Kim, Kyungpil, et al.
Publicado: (2014)

Evaluation of LDL goal achievement in statin consumption, south east of Iran
por: Aghasizadeh, Malihe, et al.
Publicado: (2021)

Statins: Cholesterol guidelines and Indian perspective
por: Menon, Anil S., et al.
Publicado: (2015)

Cardiovascular mortality after intensive LDL-Cholesterol lowering: Does baseline LDL-Cholesterol really matter?
por: Khan, Safi U., et al.
Publicado: (2020)

Nurse-coordinated care improves the achievement of LDL cholesterol targets through more intensive medication titration
por: Snaterse, Marjolein, et al.
Publicado: (2017)

Intensive lipid-lowering therapy for early achievement of guideline-recommended LDL-cholesterol levels in patients with ST-elevation myocardial infarction (“Jena auf Ziel”)
por: Makhmudova, Umidakhon, et al.
Publicado: (2023)

The Promise and Challenge of Induced Pluripotent Stem Cells for Cardiovascular Applications
por: Youssef, Amr A., et al.
Publicado: (2016)

Individualized initiation of statin therapy determined by baseline LDL-C: Are you more likely to achieve goal LDL-C?
por: Clem, James R, et al.
Publicado: (2009)

Pharmacogenetic meta-analysis of genome-wide association studies of LDL cholesterol response to statins
por: Postmus, Iris, et al.
Publicado: (2014)

LDL-cholesterol targets as Achilles’ heel of 2020 ISH guidelines
por: Filipiak, Krzysztof J.
Publicado: (2021)

Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta‐Analysis
por: Zhang, Xin‐Lin, et al.
Publicado: (2019)

Treatment patterns and low-density lipoprotein cholesterol (LDL-C) goal attainment among patients receiving high- or moderate-intensity statins
por: Fox, Kathleen M., et al.
Publicado: (2017)

LDL-cholesterol change and goal attainment following statin intensity titration among Asians in primary care: a retrospective cohort study
por: Fang, Hao Sen Andrew, et al.
Publicado: (2021)

Should We Intensify Statin Management in ACS Patients with Very Low LDL Cholesterol Levels?
por: Han, Ki Hoon
Publicado: (2019)

Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events
por: Sakuma, Masashi, et al.
Publicado: (2022)

Enhanced Quality Measurement Event Detection: An Application to Physician Reporting
por: Tamang, Suzanne R., et al.
Publicado: (2017)

Beyond LDL-Cholesterol: The Role of Low HDL-Cholesterol and Elevated TG in Residual Cardiovascular Risk Remaining After Statin Therapy
por: Watson, Karol E.
Publicado: (2008)

Assessment of the Efficacy of Lowering LDL Cholesterol with Rosuvastatin 10 mg in Four Korean Statin Benefit Groups as per ACC/AHA Guidelines (NewStaR4G)
por: Kim, Kyung-Jin, et al.
Publicado: (2020)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Effect of LDL cholesterol, statins and presence of mutations on the prevalence of type 2 diabetes in heterozygous familial hypercholesterolemia
por: Climent, Elisenda, et al.
Publicado: (2017)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Goal Among Patients with Type 2 Diabetes and Dyslipidemia
por: Alwhaibi, Monira, et al.
Publicado: (2019)

Statin treatment and LDL-cholesterol treatment goal attainment among individuals with familial hypercholesterolaemia in primary care
por: Iyen, Barbara, et al.
Publicado: (2021)

Differential influences of LDL cholesterol on functional outcomes after intravenous thrombolysis according to prestroke statin use
por: Kang, You-Ri, et al.
Publicado: (2022)

Practice-Based Evidence: Profiling the Safety of Cilostazol by Text-Mining of Clinical Notes
por: Leeper, Nicholas J., et al.
Publicado: (2013)

Association of Contemporary Statin Pretreatment Intensity and LDL-C Levels on the Incidence of STEMI Presentation
por: Dadon, Ziv, et al.
Publicado: (2021)

Type of dyslipidemia and achievement of the LDL-cholesterol goal in chronic kidney disease patients at the University Hospital
por: Sangsawang, Tamon, et al.
Publicado: (2015)

Targeting LDL Cholesterol With LNA
por: Krieg, Arthur M
Publicado: (2012)

Cellular itinerary of LDL cholesterol
por: Vance, Jean E.
Publicado: (2022)

High‐Intensity Versus Non‐High‐Intensity Statins in Patients Achieving Low‐Density Lipoprotein Cholesterol Goal After Percutaneous Coronary Intervention
por: Kim, Juwon, et al.
Publicado: (2018)

Low LDL Cholesterol, Albuminuria, and Statins for the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
por: Yang, Xilin, et al.
Publicado: (2009)

Modelling approach to simulate reductions in LDL cholesterol levels after combined intake of statins and phytosterols/-stanols in humans
por: Eussen, Simone RBM, et al.
Publicado: (2011)

LDL-cholesterol trajectories and statin treatment in Finnish type 2 diabetes patients: a growth mixture model
por: Inglin, Laura, et al.
Publicado: (2021)

Sex, Prescribing Practices and Guideline Recommended, Blood Pressure, and LDL Cholesterol Targets at Baseline in the BARI 2D Trial
por: Magee, Michelle F., et al.
Publicado: (2015)

Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients
por: Thongtang, Nuntakorn, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_6rpr7ha6evngltf136766c3unr